|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.60 INR | -2.00% |
|
-6.26% | +63.58% |
| 21/05 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 20/05 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 629.74Cr 6.57Cr 5.77Cr 5.38Cr 4.94Cr 9.27Cr 9.4Cr 64Cr 25Cr 310.82Cr 25Cr 24Cr 1.08TCr | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 716.04Cr 7.47Cr 6.57Cr 6.11Cr 5.62Cr 11Cr 11Cr 73Cr 28Cr 353.41Cr 28Cr 27Cr 1.22TCr | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.79% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -2.00% | ||
| 1 week | -6.26% | ||
| Current month | -5.39% | ||
| 1 month | -5.05% | ||
| 3 months | +40.77% | ||
| 6 months | +65.10% | ||
| Current year | +63.58% |
| 1 week | 117.6 | 122.5 | |
| 1 month | 111.5 | 126.3 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 01/01/2002 |
| Director of Finance/CFO | - | 01/04/2019 | |
| Director of Finance/CFO | - | 01/01/1991 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 01/01/1990 |
| Director/Board Member | - | 01/01/1991 | |
Prakash Sapkal
BRD | Director/Board Member | - | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.00% | -6.26% | +3.38% | +3.75% | 6.67Cr | ||
| +1.68% | +2.13% | +16.17% | +77.49% | 4.84TCr | ||
| +1.52% | +2.95% | +60.39% | +112.28% | 3.58TCr | ||
| -0.09% | -0.66% | -8.03% | +31.90% | 1.18TCr | ||
| -0.05% | -3.10% | +13.50% | +77.95% | 1.15TCr | ||
| -0.37% | -0.37% | +37.53% | +142.08% | 901.45Cr | ||
| +0.18% | +0.58% | +49.62% | -9.13% | 698.99Cr | ||
| +0.95% | -2.00% | +12.78% | +32.58% | 669.73Cr | ||
| +0.18% | -1.77% | +2.36% | +172.36% | 642.34Cr | ||
| +3.51% | -10.57% | -31.55% | +0.09% | 529.99Cr | ||
| Average | +0.55% | -1.52% | +15.61% | +64.14% | 1.42TCr | |
| Weighted average by Cap. | +1.11% | -0.15% | +25.52% | +81.59% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 379.13Cr 3.95Cr 3.48Cr 3.24Cr 2.97Cr 5.58Cr 5.66Cr 38Cr 15Cr 187.13Cr 15Cr 15Cr 647.45Cr | 374.4Cr 3.9Cr 3.43Cr 3.2Cr 2.94Cr 5.51Cr 5.59Cr 38Cr 15Cr 184.79Cr 15Cr 14Cr 639.37Cr |
| Net income | 12Cr 12.69L 11.15L 10.39L 10L 17.92L 18.15L 1.23Cr 48.21L 6Cr 47.62L 46.59L 21Cr | 5.84Cr 6L 5L 5L 5L 9L 9L 59.12L 23.14L 2.88Cr 22.85L 22.36L 9.97Cr |
| Net Debt | 115.76Cr 1.21Cr 1.06Cr 98.85L 90.83L 1.7Cr 1.73Cr 12Cr 4.59Cr 57Cr 4.53Cr 4.43Cr 197.69Cr | 86Cr 90L 79.13L 73.7L 67.72L 1.27Cr 1.29Cr 8.74Cr 3.42Cr 43Cr 3.38Cr 3.31Cr 147.39Cr |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | ₹117.60 | -2.00% | 995 |
| 24/26/24 | ₹120.00 | -0.04% | 2,214 |
| 23/26/23 | ₹120.05 | -2.00% | 500 |
| 21/26/21 | ₹122.50 | -2.00% | 400 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















